Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abiraterone Acetate in Patients With Chemotherapy-Naïve mCRPC"

108 views
December 5, 2023
Comments 0
Login to view comments. Click here to Login